According to Cardinal Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 49.0339. At the end of 2021 the company had a P/E ratio of 26.8.
Year | P/E ratio | Change |
---|---|---|
2021 | 26.8 | 136.83% |
2020 | 11.3 | -419.24% |
2019 | -3.55 | -99.52% |
2018 | -743 | -7124.48% |
2017 | 10.6 | -38.25% |
2016 | 17.1 | -20.34% |
2015 | 21.5 | -12.87% |
2014 | 24.7 | -59.35% |
2013 | 60.7 | 391.14% |
2012 | 12.4 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() CVS Health CVS | 23.4 | -52.31% | ๐บ๐ธ USA |
![]() Henry Schein
HSIC | 16.6 | -66.08% | ๐บ๐ธ USA |
![]() Teleflex TFX | 30.6 | -37.50% | ๐บ๐ธ USA |
![]() AmerisourceBergen
ABC | 22.6 | -53.83% | ๐บ๐ธ USA |
![]() McKesson MCK | 17.9 | -63.48% | ๐บ๐ธ USA |
![]() Premier PINC | 16.9 | -65.47% | ๐บ๐ธ USA |
![]() Patterson Companies
PDCO | 13.6 | -72.17% | ๐บ๐ธ USA |
![]() Allscripts MDRX | 23.4 | -52.20% | ๐บ๐ธ USA |
![]() Owens & Minor
OMI | -38.2 | -177.93% | ๐บ๐ธ USA |
![]() Herbalife HLF | 4.69 | -90.43% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.